Apoquel vs Cytopoint: Comparing Itch Relief Options for Dogs

By Emiel Maddens  ·  Reviewed in consultation with licensed veterinary professionals  ·  Updated April 2026  ·  12 min read

Photo by Anya Prygunova on Unsplash

If your dog has been diagnosed with atopic dermatitis, your veterinarian has likely mentioned two of the most commonly prescribed itch-relief options: Apoquel and Cytopoint. Both medications have transformed how veterinarians manage allergic itch in dogs, offering targeted relief without the broad side-effect profile of corticosteroids. However, they work through completely different biological pathways, come in different formats, and suit different dogs in different situations.

Choosing between Apoquel and Cytopoint can feel overwhelming, especially when your dog is miserable and you want fast results. This guide breaks down how each medication works, how quickly it takes effect, what it costs over time, the side effects to watch for, and which dogs tend to do better on which option. Understanding the differences will help you have a more productive conversation with your veterinarian about the best plan for your dog's skin.

What Are Apoquel and Cytopoint?

Apoquel (oclacitinib maleate) is an oral Janus kinase (JAK) inhibitor manufactured by Zoetis. It was FDA-approved for dogs in 2013 and works by blocking specific enzymes involved in the itch and inflammation signaling cascade. Cytopoint (lokivetmab) is a monoclonal antibody injection, also manufactured by Zoetis, that was FDA-approved in 2016. Instead of blocking enzymes, it targets and neutralizes interleukin-31 (IL-31), a key cytokine that triggers the itch sensation in dogs with atopic dermatitis. Both medications are prescription-only and designed specifically for canine use. Neither is a cure for atopic dermatitis, but both can dramatically reduce the scratching, licking, and skin damage that make the condition so distressing.

How Each Medication Works

Although both Apoquel and Cytopoint reduce allergic itch, they do so through fundamentally different biological mechanisms. Understanding these pathways helps explain why some dogs respond well to one but not the other, and why your veterinarian might recommend trying both before settling on a long-term plan.

Apoquel: JAK1 Enzyme Inhibition

Oclacitinib works by selectively inhibiting Janus kinase 1 (JAK1), an intracellular enzyme that transmits signals from multiple pro-itch and pro-inflammatory cytokines, including IL-31, IL-4, and IL-13. By blocking JAK1, Apoquel interrupts the downstream signaling cascade before it can trigger the itch sensation in sensory neurons or activate inflammatory pathways in the skin. Because JAK1 mediates signals from multiple cytokines, Apoquel has a broader anti-itch and anti-inflammatory effect. However, this broader reach also means it can affect some immune functions, which is why veterinarians monitor dogs on long-term Apoquel therapy.

Cytopoint: Targeted IL-31 Neutralization

Lokivetmab is a caninized monoclonal antibody, meaning it is engineered to closely match the structure of a natural canine antibody. It binds specifically to circulating interleukin-31 (IL-31) and neutralizes it before it can attach to receptors on sensory neurons. Since IL-31 is the primary cytokine responsible for triggering the itch signal in atopic dogs, neutralizing it can provide significant itch relief. Because Cytopoint targets only IL-31, it does not broadly suppress immune function the way some other treatments can. The antibody is broken down naturally by the body over 4 to 8 weeks, which is why the injection needs to be repeated monthly.

Onset and Duration Compared

Apoquel begins reducing itch within 4 hours of the first dose and reaches full clinical effect within 24 hours, making it one of the fastest-acting itch medications available. However, it must be given twice daily for the first 14 days, then once daily for maintenance, and itch returns within 12 to 24 hours if a dose is missed. Cytopoint takes 1 to 3 days to reach peak effect after injection, so it is slightly slower to kick in. Once active, though, a single injection provides relief for 4 to 8 weeks in most dogs, with some dogs getting a full 8 weeks of control from each dose.

Cost Comparison Over Time

The cost of each medication varies by veterinary clinic, dog size, and geographic region. Apoquel typically costs between $2 and $3 per tablet, which for a medium-sized dog translates to roughly $60 to $90 per month on maintenance dosing. Cytopoint injections usually range from $50 to $150 per dose depending on the dog's weight, given every 4 to 8 weeks. For many dog owners, the monthly costs end up being comparable. Dogs that get a full 8 weeks from each Cytopoint injection may find it slightly less expensive, while dogs that need injections every 4 weeks may find Apoquel more cost-effective. Your veterinarian can help estimate costs based on your dog's specific weight and response history.

Persistent scratching from atopic dermatitis often requires targeted therapy like Apoquel or Cytopoint to control.

Photo by Tima Miroshnichenko on Pexels

Which Breeds Benefit Most?

Certain breeds are predisposed to canine atopic dermatitis and are more likely to need medications like Apoquel or Cytopoint for long-term itch management. These breeds often benefit from early intervention to prevent secondary infections from chronic scratching.

• French Bulldog: French Bulldogs have a high prevalence of atopic dermatitis and frequently require ongoing itch management. Their skin folds can complicate treatment, making targeted therapies like Apoquel or Cytopoint especially valuable.
• Labrador Retriever: Labs are one of the most commonly affected breeds for atopy. Many Labrador owners find long-term success with either Apoquel or Cytopoint, often combined with omega-3 supplementation.
• Golden Retriever: Golden Retrievers are genetically predisposed to environmental allergies and often need year-round itch control. Their dense double coat can mask early skin changes, so persistent scratching warrants prompt veterinary evaluation.
• West Highland White Terrier: Westies have one of the highest breed-specific rates of atopic dermatitis. Many require combination therapy, and veterinary dermatologists frequently use Apoquel or Cytopoint as a foundation of their treatment plans for this breed.
• Bulldog: English Bulldogs commonly develop atopic dermatitis alongside skin fold dermatitis, creating a complex management challenge that often benefits from targeted systemic itch control.

Conditions This Addresses

Apoquel and Cytopoint are primarily indicated for canine atopic dermatitis, but the itch they address often overlaps with or triggers other skin conditions. Understanding these related conditions can help you and your veterinarian develop a comprehensive treatment plan.

• Canine Atopic Dermatitis: The primary condition both Apoquel and Cytopoint are designed to manage. Atopic dermatitis is a chronic inflammatory skin disease driven by environmental allergens.
• Yeast Dermatitis in Dogs: Chronic scratching from atopy disrupts the skin barrier, creating warm, moist conditions where Malassezia yeast can overgrow. Managing itch with Apoquel or Cytopoint helps prevent secondary yeast infections.
• Pyoderma in Dogs: Bacterial skin infections frequently develop secondary to atopic dermatitis. Reducing itch and self-trauma with targeted medications helps the skin barrier heal and resist infection.
• Hot Spots in Dogs: Acute moist dermatitis (hot spots) often develops when allergic dogs scratch or lick one area intensely. Controlling the underlying itch can prevent hot spot formation.
• Flea Allergy Dermatitis: Dogs with atopic dermatitis often have concurrent flea allergy. While Apoquel and Cytopoint can reduce itch, rigorous flea prevention remains essential for these dogs.

How Each Medication Is Used

Apoquel and Cytopoint differ significantly in how they are administered, stored, and managed day-to-day. These practical differences matter, because owner compliance directly affects treatment outcomes.

Apoquel Administration

Apoquel is given as an oral tablet, available in 3.6 mg, 5.4 mg, and 16 mg strengths. The standard dose is 0.4 to 0.6 mg/kg twice daily for the first 14 days, then once daily for maintenance. It can be given with or without food. Tablets should not be split or crushed unless directed by a veterinarian. Apoquel is approved for dogs 12 months of age and older, as safety in younger dogs has not been fully established.

Cytopoint Administration

Cytopoint is administered as a subcutaneous injection by your veterinarian. The dose is weight-based (2 mg/kg minimum), and the injection is given every 4 to 8 weeks depending on individual response. Since it requires a veterinary visit for each injection, it eliminates concerns about daily medication compliance. Cytopoint has no minimum age requirement and can be used in dogs of any age, which makes it a particularly useful option for puppies with early-onset atopy.

Combining with Other Treatments

Both Apoquel and Cytopoint can be used alongside other allergy management strategies, including medicated shampoos, omega-3 fatty acid supplements, and elimination diets for dogs with concurrent food sensitivities. Some veterinary dermatologists use Apoquel and Cytopoint together during severe flares, though this combination approach should only be done under direct veterinary supervision. Topical therapies like chlorhexidine rinses remain important for managing secondary infections regardless of which systemic medication is chosen.

What to Look For When Choosing Between Them

There is no single best choice that applies to every dog. The right medication depends on your dog's specific response, your lifestyle, your budget, and your veterinarian's clinical judgment. Here are the key factors to consider.

Speed of Relief Needed

If your dog is in acute distress and you need the fastest possible itch relief, Apoquel's 4-hour onset gives it an advantage over Cytopoint's 1 to 3 day ramp-up. Some veterinarians prescribe a short course of Apoquel to bridge the gap while waiting for Cytopoint to take effect.

Owner Compliance and Lifestyle

If remembering daily medication is challenging, Cytopoint's monthly injection schedule may be more practical. Conversely, if your dog is difficult to transport to the vet or becomes extremely stressed during visits, daily oral Apoquel at home may be preferable.

Concurrent Health Conditions

Dogs with a history of recurrent infections, demodicosis, or neoplasia may be better candidates for Cytopoint, since it does not broadly suppress immune signaling the way Apoquel can. Dogs with injection-site sensitivities or those who have had adverse reactions to biologic therapies may do better on oral Apoquel.

Response to Treatment

Approximately 60 to 70% of atopic dogs show significant improvement on Apoquel, and similar response rates are reported for Cytopoint. However, individual dogs vary, and some respond well to one medication but not the other. Your veterinarian may recommend trying both sequentially to identify which provides the best control for your specific dog.

Potential Side Effects and Risks

Both Apoquel and Cytopoint have favorable safety profiles compared to corticosteroids, but they are not without potential risks. Understanding the side effect profile of each medication helps you monitor your dog effectively and report any concerns to your veterinarian early.

Apoquel Side Effects

The most commonly reported side effects of Apoquel include vomiting, diarrhea, decreased appetite, and lethargy during the initial loading phase. Because oclacitinib partially suppresses JAK-mediated immune pathways, long-term use has been associated with increased susceptibility to bacterial and fungal skin infections, demodicosis, and papillomas (viral warts). Rare cases of lymphoma and other neoplasia have been reported in post-market surveillance, although a direct causal link has not been established. Zoetis recommends baseline bloodwork and periodic monitoring for dogs on long-term Apoquel therapy.

Cytopoint Side Effects

Cytopoint has a very low side-effect profile because it acts as a targeted antibody rather than a broad enzyme inhibitor. The most commonly reported adverse events are mild injection-site reactions and, rarely, transient vomiting within 24 hours of injection. Because lokivetmab is a caninized antibody, the risk of immune-mediated reactions is low, though not zero. Anti-drug antibodies can develop in some dogs over time, potentially reducing efficacy after several months of treatment. If you notice that Cytopoint seems to be wearing off faster, your veterinarian can evaluate whether antibody development may be involved.

Drug Interactions

Apoquel should be used with caution in dogs concurrently receiving other immunosuppressive medications such as corticosteroids or cyclosporine, as additive immunosuppression can increase infection risk. Cytopoint has no known significant drug interactions, which is one of its advantages for dogs on complex medication regimens. Always provide your veterinarian with a complete medication list before starting either therapy.

When to See Your Vet Instead

While both Apoquel and Cytopoint are generally safe when used as directed, certain situations require prompt veterinary attention. If any of the following apply, contact your veterinarian or a veterinary dermatologist right away.

Treatment Failure or Declining Response

If your dog was previously well-controlled on either medication and begins scratching intensely again, this could indicate dose adjustment is needed, a secondary infection has developed, or a new allergen is involved. Do not increase the dose on your own, as both medications require veterinary dosing decisions.

Signs of Infection

Pustules, crusting, hair loss, or a foul odor developing on the skin while on itch medication may indicate a secondary bacterial or yeast infection that needs separate treatment. Itch-relief medications do not treat infections, so concurrent antimicrobial therapy may be necessary.

Considering Switching Medications

If you are thinking about switching from Apoquel to Cytopoint or vice versa, always do this under veterinary guidance. Your veterinarian can manage the transition to avoid gaps in itch control and can evaluate whether combination therapy during the switch period is appropriate.

Related Symptoms

Dogs undergoing this treatment often present with these symptoms. Our guides explain each one:

• Dog Paw Licking, Persistent paw licking is one of the hallmark signs of atopic dermatitis and often one of the first symptoms owners notice.
• Dog Belly Redness, Ventral erythema (red belly skin) is a common presentation in atopic dogs and often improves with targeted itch-relief therapy.
• Dog Ear Infections, Recurrent otitis externa frequently accompanies canine atopy and may require separate treatment alongside systemic itch management.
• Dog Night Scratching, Allergic itch often intensifies at night, disrupting sleep for both dogs and owners. Effective itch control restores restful sleep.

Frequently Asked Questions: Apoquel vs Cytopoint

Q: Can my dog take Apoquel and Cytopoint at the same time?

Some veterinary dermatologists do use both concurrently during severe flares, but this should only be done under direct veterinary supervision. Using both together is generally a short-term strategy rather than a long-term maintenance plan.

Q: Which one works faster for itch relief?

Apoquel typically begins reducing itch within 4 hours of the first dose, while Cytopoint takes 1 to 3 days to reach peak effect. For immediate relief during an acute flare, Apoquel has the faster onset.

Q: Is Cytopoint safer than Apoquel for long-term use?

Cytopoint has a narrower mechanism targeting only IL-31, which means it does not broadly affect immune function the way Apoquel can. Many veterinary dermatologists consider it to have a more favorable long-term safety profile, but both medications have been used safely in dogs for years under veterinary supervision.

Q: Why did my dog stop responding to Cytopoint?

Some dogs develop anti-drug antibodies against lokivetmab over time, which can reduce its effectiveness. If Cytopoint seems to be wearing off faster than before, your veterinarian may recommend switching to Apoquel or exploring other options like allergy testing and immunotherapy.

Q: Are there natural alternatives to Apoquel and Cytopoint?

While omega-3 fatty acids, probiotics, and natural anti-inflammatory supplements can support skin health, they generally do not provide sufficient itch relief for dogs with moderate to severe atopic dermatitis. They work best as adjunctive therapies alongside prescription medications.

Q: Can puppies take Apoquel or Cytopoint?

Cytopoint has no minimum age restriction and can be used in puppies. Apoquel is approved only for dogs 12 months of age and older, so Cytopoint is the preferred option for young dogs with atopic dermatitis.

Sources

Cosgrove SB, Wren JA, Cleaver DM, et al. Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis. Veterinary Dermatology. 2013;24(5):479-e114.

Michels GM, Ramsey DS, Walsh KF, et al. A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized anti-canine IL-31 monoclonal antibody in client-owned dogs with atopic dermatitis. Veterinary Dermatology. 2016;27(6):478-e129.

Olivry T, DeBoer DJ, Favrot C, et al. Treatment of canine atopic dermatitis: 2015 updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA). BMC Veterinary Research. 2015;11:210.

Gonzales AJ, Humphrey WR, Messamore JE, et al. Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis. Veterinary Dermatology. 2013;24(1):48-e12.

Marsella R, Olivry T, Carlotti DN. Current evidence of skin barrier dysfunction in human and canine atopic dermatitis. Veterinary Dermatology. 2011;22(3):239-248.

Souza CP, Rosychuk RAW, Contreras ET, et al. A retrospective analysis of the use of lokivetmab in the management of allergic pruritus in a referral population of 135 dogs in the western USA. Veterinary Dermatology. 2018;29(6):489-e164.

Related Reading

• Canine Atopic Dermatitis: Complete Guide, A comprehensive overview of the condition both Apoquel and Cytopoint are designed to treat, including diagnosis, triggers, and long-term management strategies.
• When to See a Veterinary Dermatologist, If standard itch management is not providing adequate control, a board-certified veterinary dermatologist can offer advanced diagnostic and treatment options.
• Dog Allergy Testing: Intradermal vs Serum, Understanding what your dog is allergic to can help guide long-term treatment decisions, including whether immunotherapy might reduce the need for medications.
• Natural Allergy Relief for Dogs, Complementary approaches that may be used alongside Apoquel or Cytopoint to support skin health and potentially reduce medication dependence.

Emiel Maddens

Founder of Vetified. Develops topical antifungal and antimicrobial formulations for companion animals. Vetified products are listed on DailyMed and manufactured through FDA-registered facilities in the United States.